Search

Search Constraints

You searched for: Author/Creator Larsen, Jill E.

Search Results

1. Abstracts Presented by Attendees. (February 2016)

2. Combined use of subclinical hydroxyurea and CHK1 inhibitor effectively controls melanoma and lung cancer progression, with reduced normal tissue toxicity compared to gemcitabine. Issue 7 (14th June 2019)

4. Original Article: Translational Oncology - Validation of SCT Methylation as a Hallmark Biomarker for Lung Cancers. Issue 3 (March 2016)

5. Validation ofSCTMethylation as a Hallmark Biomarker for Lung Cancers. Issue 3 (March 2016)